T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Gogo Inc
GOGO
$377M
| $443K | ﹤0.01% |
43,731
+1,042
| +2% | +$11.1K |
|
2227
Hims & Hers Health
HIMS
$6.71B
| $442K | ﹤0.01% |
49,579
+2,922
| +6% | +$21.6K |
|
2228
TETRA Technologies
TTI
$1.25B
| $441K | ﹤0.01% |
97,457
+8,900
| +10% | +$44.9K |
|
2229
8x8 Inc
EGHT
$303M
| $438K | ﹤0.01% |
115,780
-5,993
| -5% | -$17.8K |
|
|
RYZ
2230
Ryerson Holding Corp
RYZ
$1.5B
| $437K | ﹤0.01% |
12,576
+1,486
| +13% | +$44.3K |
|
2231
Pathward Financial
CASH
$1.79B
| $435K | ﹤0.01% |
8,217
+86
| +1% | +$4.23K |
|
2232
Health Catalyst
HCAT
$132M
| $435K | ﹤0.01% |
46,915
+4,941
| +12% | +$40.4K |
|
2233
Pulmonx
LUNG
$92.8M
| $435K | ﹤0.01% |
34,087
+580
| +2% | +$6.04K |
|
2234
Shutterstock
SSTK
$217M
| $434K | ﹤0.01% |
8,979
+617
| +7% | +$26K |
|
|
CHS
2235
DELISTED
Chicos FAS, Inc.
CHS
| $432K | ﹤0.01% |
56,920
+1,822
| +3% | +$13.7K |
|
2236
Editas Medicine
EDIT
$432M
| $431K | ﹤0.01% |
42,530
-1,262
| -3% | -$11.1K |
|
2237
FRP Holdings
FRPH
$425M
| $430K | ﹤0.01% |
13,662
+274
| +2% | +$7.87K |
|
2238
Greenlight Captial
GLRE
$512M
| $430K | ﹤0.01% |
37,635
+2,565
| +7% | +$28.5K |
|
2239
Vera Bradley
VRA
$94.7M
| $430K | ﹤0.01% |
55,792
+1,057
| +2% | +$7.7K |
|
|
SLCA
2240
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $429K | ﹤0.01% |
37,916
+5,054
| +15% | +$59.9K |
|
2241
Camden National
CAC
$996M
| $428K | ﹤0.01% |
11,364
-1,631
| -13% | -$53.2K |
|
2242
Orthofix Medical
OFIX
$415M
| $428K | ﹤0.01% |
31,721
+977
| +3% | +$11.5K |
|
2243
Green Dot
GDOT
$770M
| $426K | ﹤0.01% |
42,984
+6,362
| +17% | +$66.3K |
|
2244
Simulations Plus
SLP
$370M
| $425K | ﹤0.01% |
9,486
+1,397
| +17% | +$55.4K |
|
2245
NIO
NIO
$11.3B
| $423K | ﹤0.01% |
46,600
| – | – |
|
2246
Sweetgreen
SG
$721M
| $422K | ﹤0.01% |
37,291
+2,462
| +7% | +$25.9K |
|
|
CHCT
2247
Community Healthcare Trust
CHCT
$433M
| $421K | ﹤0.01% |
15,767
+2,710
| +21% | +$74.6K |
|
2248
Harmony Biosciences
HRMY
$2.24B
| $421K | ﹤0.01% |
13,018
+620
| +5% | +$17.3K |
|
2249
SSR Mining
SSRM
$6.49B
| $421K | ﹤0.01% |
39,047
+4,577
| +13% | +$55.6K |
|
2250
Stem
STEM
$55.9M
| $421K | ﹤0.01% |
5,419
+1,014
| +23% | +$69.9K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.